HALO — Halozyme Therapeutics, Inc. | XLV Holdings | StockAdder

(HALO)

Halozyme Therapeutics, Inc.

Live chart and latest HALO stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

HALO News

Is Halozyme Therapeutics (HALO) Stock Price Out Of Step With Recent Valuation Signals

Feb 18, 2026 PR Newswire

Halozyme Appoints David Ramsay as Interim Chief Financial Officer

Mar 12, 2026 MSN

Halozyme Therapeutics (HALO) appoints interim CFO amid growth plans

Mar 30, 2026 Investing.com

Halozyme Therapeutics CEO Helen Torley sells $634,981 in stock

Apr 7, 2026 simplywall.st

Is Halozyme Therapeutics (HALO) Pricing Reflect Its Potential After Recent Share Price Pullback

Mar 31, 2026 FinancialContent

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO

Apr 10, 2026 Stock Titan

Halozyme (NASDAQ: HALO) CEO sells 10,000 shares after option exercise

Apr 7, 2026 ChartMill

HALOZYME THERAPEUTICS INC (NASDAQ:HALO): A GARP Stock with Strong Growth and Reasonable Valuation

Feb 17, 2026 Yahoo Finance

Unpacking Q4 Earnings: Halozyme Therapeutics (NASDAQ:HALO) In The Context Of Other Therapeutics Stocks

Mar 25, 2026 Stock Titan

Halozyme (NASDAQ: HALO) CEO exercises 40k options, sells 40k shares

Apr 2, 2026 Yahoo Finance

Halozyme Therapeutics (HALO) Valuation Check As Recent Share Pullback Follows Strong Multi Year Returns

Mar 4, 2026 Yahoo Finance

Here’s What Analysts Think About Halozyme Therapeutics (HALO)

Dec 31, 2025 Yahoo Finance

Assessing Halozyme Therapeutics (HALO) Valuation After Recent Share Price Consolidation

Jan 21, 2026 Yahoo Finance

Reframing The Narrative For Halozyme Therapeutics (HALO) After The Latest Analyst Price Target

Jan 21, 2026 Yahoo Finance

Is Halozyme Therapeutics (HALO) a Buy Post Earnings?